Results

Total Results: 1,240 records

Showing results for "death".

  1. www.uspreventiveservicestaskforce.org/home/getfilebytoken/aD-Br2oTJ67FeNdHHkLtPA
    April 22, 2004 - Intense craving, stress from the lifestyle Psychosis after repeated use of high doses Sudden death … repeated use of high doses Permanent damage to brain cells Liver damage, brain haemorrhage, sudden death … reactions, hypoxia Delirium, seizures, coma, organ damage (heart, lungs, liver, kidneys) Death … Severe withdrawal symptoms Overdose and death if used with alcohol, opioids or other depressant drugs … work problems, violations of law Tolerance and dependence, withdrawal symptoms Overdose and death
  2. www.uspreventiveservicestaskforce.org/uspstf/recommendation/v1-breast-cancer-medications-for-risk-reduction--s
    July 08, 2002 - archived Final Recommendation Statement Breast Cancer: Medications for Risk Reduction July 08, 2002 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Departm…
  3. www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction-2002
    July 08, 2002 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Recommendation Statement Breast Cancer: Medications for Risk Reduction July 08, 2002 Recommendations made by the USPSTF are independent of the U.S. gove…
  4. www.uspreventiveservicestaskforce.org/home/getfilebytoken/We5A-uCMvX5qYeFukGgqks
    March 01, 2004 - Death was definitely associated with biopsy in 2 of 1,500 patients and was possibly associated with biopsy … cirrhosis; 0.135 [95% CI, incidence of 0.049–0.372]) hepatocellular cancer and Adjusted RR for death … evidence regarding reduce the risk for or rate benefits of screening in the of harm and premature deathdeath, perforation) from liver biopsy was approximately 1%–2%, with mortality less than 0.3%. … biopsy complications observational study complications and complications who have major (bleeding, death
  5. www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-use-prevent-cardiovascular-disease-colorectal-cancer-preventive-medication-2002
    January 01, 2002 - including ischemic coronary heart disease, stroke, and peripheral vascular disease, is the leading cause of death … Collaborative overview of randomised trials of antiplatelet therapy—I: Prevention of death, myocardial
  6. www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening-1996
    January 01, 1996 - Suffering Cancer of the lung is the leading cause of death … produced similar results. 24 The investigators found no substantial difference in the number or causes of death
  7. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary43/prostate-cancer-screening-2012
    October 07, 2011 - Prostatectomy was associated with perioperative death (about 0.5%) and cardiovascular events (0.6% to … for an estimated 1410 men invited to screening and 48 treated to prevent 1 prostate cancer–specific death … overdiagnosis because of the detection of low-risk cancers that would not have caused morbidity or death … PSA-based screening identifies more prostate cancers, but most trials found no effect on risk for death … Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized
  8. www.uspreventiveservicestaskforce.org/home/getfilebytoken/sTjqbTas6gW5pzaATpeBDn
    January 01, 2013 - hormone therapy in- creases the risk for invasive breast cancer incidence and possibly breast cancer death … Cardiovascular Events The primary outcome of interest in WHI was the rate of CHD (defined as CHD death … post hoc analysis reported that the use of combined therapy was associated with an increased risk for death
  9. www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/integrating-evidence-based-clinical-and-community-strategies-improve-health
    March 12, 2021 - conducive to health increase the risk of disease and injury and contribute to the leading causes of death … Actual causes of death in the United States, 2000.  JAMA  2004;291(10):1238-45. … Correction: actual causes of death in the United States, 2000. JAMA 2005;293(3):293-4.
  10. www.uspreventiveservicestaskforce.org/uspstf/recommendation/drug-use-illicit-primary-care-interventions-for-children-and-adolescents
    May 26, 2020 - health, social, and economic consequences and is a significant contributor to 3 of the leading causes of death … alcohol and illicit drugs are the primary health risk behaviors that contribute to these causes of death
  11. www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/ipv-abuse-bulletin.pdf
    November 25, 2024 - bones, pain, anxiety, depression, sexually transmitted infections, unintended pregnancy, and risk of death
  12. www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/osteoporosis-screening-final-rec-bulletin.pdf
    January 14, 2025 - normal, healthy bone and can result in serious disability, chronic pain, loss of independence, and even death
  13. www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening-2008
    October 15, 2008 - Colorectal cancer is the third most common type of cancer and the second leading cause of cancer death … for all the screening methods, with the highest risks for morbidity, hospitalization, and (rarely) death
  14. www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/child-maltreatment-interventions-final-rec-bulletin.pdf
    March 19, 2024 - Maltreatment can lead to devastating effects, such as injury and death, and can also lead to long-term
  15. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-statins/statin-use-in-adults-preventive-medication
    November 13, 2016 - For the JUPITER trial, we interpreted “MI, stroke, or cardiovascular death” as reported in the main trial … publication (2) as “myocardial death, stroke death, or cardiovascular death,” when it meant “nonfatal … myocardial infarction, nonfatal stroke, or cardiovascular death.” … adverse outcomes of CVD is that the first clinical manifestation can be catastrophic, including sudden cardiac … to prevent 1 cardiovascular death was 500 after 2 to 6 years.
  16. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-statins/statin-use-in-adults-preventive-medication-november-2016
    November 13, 2016 - For the JUPITER trial, we interpreted “MI, stroke, or cardiovascular death” as reported in the main trial … publication (2) as “myocardial death, stroke death, or cardiovascular death,” when it meant “nonfatal … myocardial infarction, nonfatal stroke, or cardiovascular death.” … adverse outcomes of CVD is that the first clinical manifestation can be catastrophic, including sudden cardiac … to prevent 1 cardiovascular death was 500 after 2 to 6 years.
  17. www.uspreventiveservicestaskforce.org/uspstf/procedure-manual/procedure-manual-appendix-xiii-template-scoping-decision-problem-address-through-decision-modeling
    July 01, 2017 - Procedure Manual Appendix XIII. Template for Scoping the “Decision Problem” to Address Through Decision Modeling Date: P…
  18. www.uspreventiveservicestaskforce.org/uspstf/behavioral-counseling-interventions-an-evidence-based-approach---table-1
    November 01, 2013 - Behavioral Counseling Interventions: An Evidence-based Approach - Table 1 Share to Facebook Share to X Share to WhatsApp Share to Email Print Table 1. Healthy People 2010 Leading Health Indicators a Health Indicator 1997 Basel…
  19. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary23/diabetes-mellitus-type-2-in-adults-screening-2008
    June 15, 2008 - of an HMG-CoA reductase inhibitor in primary and secondary prevention of cardiovascular events and death … Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. … Fair Acarbose: NSD in death from placebo; gastrointestinal side effects common. … Metformin: NSD in death, hypoglycemia, lactic acidosis vs. placebo or diet. … CHD death or nonfatal MI: DM subgroup: 0.89 (0.71-1.10); P = NR Non-DM: 0.92 (0.76-1.10);
  20. www.uspreventiveservicestaskforce.org/home/getfilebytoken/sZN5HHS8w5Sar6bBPabsaB
    June 01, 2008 - of an HMG-CoA re- ductase inhibitor in primary and secondary prevention of cardiovascular events and death … Few data exist on the effect of these interventions on cardiovascular events, death, or other long-term … Fair Acarbose: NSD in death from placebo; gastrointestinal side effects common. … Metformin: NSD in death, hypoglycemia, lactic acidosis vs. placebo or diet. … Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: